Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Alli Makes Passing Grade On Safety; Advisory Committee Debates Benefit

This article was originally published in The Tan Sheet

Executive Summary

Orlistat's benefit in an over-the-countersetting is questionable, but the safety of the weight-loss drug creates a risk/benefit ratio in favor of nonprescription use, an FDA advisory panel expressed in an 11-3 vote Jan. 23
Advertisement

Related Content

Alli Approved OTC For Weight Loss With “Goal Oriented” Indication
Alli Approved OTC For Weight Loss With “Goal Oriented” Indication
Alli Approved OTC For Weight Loss With “Goal Oriented” Indication
Xenical Off-The-Market Switch Sought By Public Citizen
Xenical Off-The-Market Switch Sought By Public Citizen
Xenical Off-The-Market Switch Sought By Public Citizen
Alli Sparks Reevaluation Of OTC Weight-Loss Indication
Future Alli Actual Use, Label Comprehension Commitments Likely
Self-Selection Doubts Are No Friend To Alli As Xenical Heads For Switch Panel
GSK’s New Year’s resolution

Topics

Advertisement
UsernamePublicRestriction

Register

PS099037

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel